[Should chemotherapy or endocrine therapy be used as first choice in patients with advanced breast cancer? A status article based on the Cochrane analysis "Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer"].
H:S Rigshospitalet, Finsencentret, Onkologisk Klinik, København. ejlertsen@rh.dk
Bent
B
Ejlertsen
Henning
H
Mouridsen
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000556:secondary; D020847:Estrogen Receptor Modulators / Q000009:adverse effects / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D015201:Meta-Analysis as Topic; D011788:Quality of Life; D015996:Survival Rate
D000970:Antineoplastic Agents; D020847:Estrogen Receptor Modulators